Stockreport

Mural Oncology to Participate in Two Upcoming Investor Conferences

Mural Oncology plc - Ordinary Shares  (MURA) 
PDF WALTHAM, Mass. and DUBLIN, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigatio [Read more]